Carcinoma, Medullary - 25 Studies Found
Terminated |
: Clinical Evaluation of 18F-DOPA Positron Emission Tomography in Medullary Thyroid Cancer :
|
Completed |
: Sunitinib Malate in Treating Patients With Iodine-Refractory Recurrent or Metastatic Thyroid Cancer :
|
Recruiting |
: Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer :
: Drug: Pazopanib Hydrochloride Given PO Other Names: |
Completed |
: Tanespimycin in Treating Patients With Inoperable Locoregionally Advanced or Metastatic Thyroid Cancer :
: |
Active, not recruiting |
: Sunitinib in Treating Patients With Thyroid Cancer That Did Not Respond to Iodine I 131 and Cannot Be Removed by Surgery :
: |
Not yet recruiting |
: Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor :
|
Active, not recruiting |
: Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid Tumors :
|
Completed |
: Suberoylanilide Hydroxamic Acid in Treating Patients With Metastatic and/or Locally Advanced or Locally Recurrent Thyroid Cancer :
|